Gastrointestinal Cancer,Pancreatic Cancer NCI-MATCH Phase II: Tolerable TRAEs from Vismdegib Oral Intake Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 eNRGy Study: Zenocutuzumab for NRG1+ Cancers Assessment Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 Study: Rucaparib-resistant BRCA/PALB2 Pancreatic Cancer Treatment Mar 27, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),Pancreatic Cancer Phase 2 Trial of Sotorasib in Advanced Pancreatic Cancer with KRAS p.G12C Mutation Mar 03, 2023
Gastrointestinal Cancer,Pancreatic Cancer Nab-Paclitaxel and Gemcitabine vs. Gemcitabine Monotherapy in Resected Pancreatic Ductal Adenocarcinoma: Phase III Results Feb 24, 2023